Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05855837
Other study ID # 2023/03/21
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 5, 2023
Est. completion date August 30, 2023

Study information

Verified date July 2023
Source General Mills
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.


Recruitment information / eligibility

Status Completed
Enrollment 228
Est. completion date August 30, 2023
Est. primary completion date June 9, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Healthy adults 18-70 years old - Habitual cereal consumers (at least several times per month) - Body mass index 18.5-24.9 kg/m2 (based on self-reported weight and height - Understand and willing to follow the study procedures - Willing to drink skim milk - Willing to maintain habitual diet, physical activity pattern, and body weight throughout the study - Willing to abstain from strenuous exercise and consuming alcoholic drinks 24 hours before the test day - Willing to provide Informed Consent to participate in the study Exclusion Criteria: - Pregnant or lactating women, or women who are planning to become pregnant during the study - Known food allergies, sensitivities, or intolerance to any food or food ingredients - Participation in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification - Taking medication(s) that affect appetite, metabolism or blood pressure - Presence of acute diseases or infection - Presence or history of chronic diseases - Diagnosed with an eating disorder - Restraint eaters as determined by score >4 from the Dutch Eating Behavior Questionnaire - Lost or gained 5 or more pounds in the past 3 months - On a weight loss diet or undergoing intermittent fasting - COVID-19 infection within the past 3 months - Subjects who do not eat cereal products

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ready to Eat Cereal
Cereal products available in retail stores

Locations

Country Name City State
United States Remote study, no physical facility Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
General Mills

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale for Hunger 0-240 minutes Visual Analogue Scale for "how hungry are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more hunger. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome. 240 minutes
Primary Visual Analogue Scale for Fullness 0-240 minutes Visual Analogue Scale for "how full are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more fullness. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome. 240 min
Primary Visual Analogue Scale for Satiation 0-240 minutes Visual Analogue Scale for "how satiated are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more satiation. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome. 0-240 min
Primary Visual Analogue Scale for Desire to Eat 0-240 minutes Visual Analogue Scale for "how strong is your desire to eat right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more desire to eat. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome. 240 min
Primary Visual Analogue Scale for Prospective Consumption 0-240 minutes Visual Analogue Scale for "how much do you think you can eat right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more prospective consumption. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome. 240 min
Primary Visual Analogue Scale for Satisfaction 0-240 minutes Visual Analogue Scale for "how satisfied are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more satisfaction. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome. 240 min
See also
  Status Clinical Trial Phase
Recruiting NCT03968718 - PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice N/A
Not yet recruiting NCT05781126 - The Effect of Listening Effort, Cognition and Anxiety-depression in Listening Satisfaction by Hearing Aid Users
Completed NCT03461640 - Community Based Doulas for Migrant Women in Labour and Birth in Sweden - a Randomised Controlled Trial N/A
Completed NCT03545698 - Enhancing and Scaling a High-Touch Home-based Primary Care Program N/A
Completed NCT03595449 - Lidocaine Jelly for Pain Control During Mohs Surgery Phase 4